US Executive Compensation Proxy SEC Filings — October 15, 2026

15-10-2026

Datacentrex, Inc. (the filing references ticker TZUP / THUMZUP MEDIA Corp per the request, though the filing body names Datacentrex, Inc. and ticker references to DTCX) has filed a DEF 14A proxy statement for its 2026 Annual Meeting of Shareholders, to be held November 30, 2026 at 11:00 a.m. ET in New York. Shareholders will vote on three matters: electing five directors, ratifying Haynie & Company as auditor for fiscal 2026, and approving a discretionary reverse stock split at a ratio between 1-for-2 and 1-for-25. The proxy materials are being distributed via Notice of Internet Availability beginning on or about October 15, 2026.

• · Reverse split authority may be exercised at any time before November 30, 2027 without further shareholder approval
• · Series D Preferred Stock holders have no voting rights and are excluded from the Record Date share count
• · Election of directors is a non-routine matter; uninstructed street-name shares will not be voted on it (broker non-votes expected)
• · Ratification of Haynie and the reverse split proposal are expected to be routine matters, allowing brokers discretionary voting
• · Voting methods include internet (www.DTCX.vote), mail, fax (347-584-3644), email ([email protected]), and in person
• · Shareholders may elect to receive proxy materials electronically or in paper form on an ongoing basis

15-10-2026

ClimateRock (CLRWF), a Cayman Islands blank-check company (SPAC), filed a DEF 14A definitive proxy statement on October 15, 2026 for a shareholder meeting on October 29, 2026, seeking approval of a Sixth Extension Amendment to extend its deadline for completing an initial Business Combination with GreenRock. The filing warns that there is no assurance the extension will enable a completed deal, that public shareholders will have redemption rights (creating potential cash shortfalls), and that the sponsor, officers and directors hold about 93.99% of voting shares, so they could approve all proposals even if public shareholders vote against them at minimum quorum.

• · Shareholder meeting scheduled for October 29, 2026 (conformed period of report).
• · Shareholders face separate redemption windows for the extension amendment and for the later Business Combination vote, which could leave insufficient cash to close a deal.
• · The 2024 SPAC Rules and possible Investment Company Act status could raise costs, delay the deal, or force liquidation.
• · On May 2, 2024, the Trust Account was moved from U.S. treasury investments to cash or an interest-bearing demand deposit account to mitigate Investment Company Act risk.
• · A 1% U.S. excise tax may apply to redemptions if the initial Business Combination involves a U.S.-organized company and the company domesticates as a Delaware corporation.

15-10-2026

Korsana Biosciences, Inc. (formerly Cyclerion Therapeutics, CYCN, as the filing references Korsana) has filed a DEF 14A proxy statement soliciting shareholder approval at a virtual special meeting on November 13, 2026 for a redomestication from Massachusetts to the Cayman Islands via domestication and continuation, along with adopting Cayman articles of association. The same proposal previously received a substantial majority of votes cast at the 2026 Annual Meeting but failed to reach the two-thirds of outstanding shares required under Massachusetts law and the two-thirds of votes properly cast required under Cayman law, so the board is re-submitting it; the filing does not specify a vote outcome, and approval is uncertain.

• · Special Meeting scheduled for November 13, 2026 at 10:30 a.m. Eastern Time, held exclusively online at www.proxydocs.com/KRSA
• · Redomestication requires both Proposal No. 1 and Proposal No. 2 to pass; the Adjournment Proposal is independent and not conditional
• · If the Redomestication fails, the Company remains a Massachusetts corporation
• · Stated anticipated benefits include reduced risk and cost of shareholder demands and litigation, greater protection for directors and officers, and greater flexibility in corporate transactions
• · Redomestication intended to qualify as a reorganization under Section 368(a)(1)(F) of the Code for U.S. federal income tax purposes
• · Post-redomestication, shareholder rights would be governed by Cayman Islands law and the Cayman Articles
• · Proxy solicitor is Innisfree M&A Incorporated; stockholder toll-free line (877) 825-8793, banks and brokers (212) 750-5833
• · Special Meeting Rules of Conduct to be posted approximately two weeks before the meeting

15-10-2026

Franklin Wireless Corp. (FKWL) filed its definitive proxy statement for a virtual Annual Meeting of Stockholders to be held December 4, 2026 at 2:00 p.m. Pacific Time. Agenda items include election of directors, ratification of the independent auditor for fiscal 2027, a non-binding advisory vote on executive compensation, and an advisory vote on the frequency of future say-on-pay votes. The filing contains no reported financial results or quantified monetary figures; it is a governance and shareholder-process disclosure.

• · Record date for stockholder voting eligibility is September 25, 2026
• · Proxy materials, Annual Report on Form 10-K for fiscal year ended June 30, 2026, and proxy card to be furnished on or about October 25, 2026
• · Meeting will be held virtually; contingency adjournment convened at 12:00 p.m. Pacific Time on the same date if technical issues arise under Nevada corporate law
• · Stockholder list available for 10 days prior to the meeting at the principal office
• · Proxy card appoints OC Kim, President, as stockholder representative
• · Filing made with no fee required (Schedule 14A, Rule 14a-101)
• · Filing contains internal inconsistencies: cover and notice refer to the '2025 Annual Meeting' and 'fiscal 2027' auditor ratification while the meeting date is in 2026; the meeting is also described as held via Zoom and via a Mountain Share Transfer link

15-10-2026

Boxlight Corp's DEF 14A proxy statement (filed October 15, 2026) describes the company's August 5, 2026 private placement of 937,500 shares of Series D Convertible Preferred Stock at $8.00 per share (stated value $10.00, 20% OID) for an aggregate subscription of $7,500,000, payable in two tranches ($5,500,000 at closing and $2,000,000 contingent on stockholder approvals and Nasdaq compliance), alongside a $15,000,000 equity line of credit. The filing reveals material governance and dilution concerns, including conversion pricing at a 20% discount with a floor price of $0.6160, a 20% default dividend and 20% default premium, and the company's failure to timely call the required special stockholder meeting, though no holder has asserted an Event of Default. Overall sentiment is negative to mixed, reflecting needed financing alongside significant dilution and contingent obligations.

• · Tranche 2 ($2.0M) is contingent on Required Stockholder Approvals, timely SEC reporting, and Nasdaq continued listing compliance, creating funding uncertainty
• · The company did not call the required special stockholder meeting within the specified periods and has no written waiver, though no holder has declared an Event of Default
• · Default triggers include a 20% annual default dividend payable in kind and a 20% automatic increase in stated value, both compounding dilution risk
• · The Certificate of Amendment (September 30, 2026) adds protective provisions requiring Series D holder approval for mergers, asset sales, and tender offers above 50% thresholds
• · Conversion floor resets semi-annually and automatically resets lower on sub-floor issuances, with the floor ceasing to apply if the stock moves to OTC Markets
• · Requested authorization for reverse splits up to 1-for-1,000 and increases in authorized Class A shares signals potential significant future dilution
• · Net proceeds are restricted to general corporate purposes and working capital and cannot repay debt, redeem equity, or settle litigation
• · Disputes are governed by Nevada law with arbitration administered by RapidRuling in New York

15-10-2026

Cactus Acquisition Corp. 1 Ltd has filed a DEF 14A proxy statement seeking shareholder approval of an Articles Extension Proposal to extend its business combination deadline beyond the current Termination Date of November 2, 2026, along with an Adjournment Proposal. The Board unanimously recommends voting FOR both proposals, and the Articles Extension Proposal requires a two-thirds special resolution; if not approved, the Trust Account will be liquidated and public warrants will expire worthless. The Meeting is scheduled for October 27, 2026, with a record date of September 30, 2026.

• · Articles Extension Proposal requires a special resolution (at least two-thirds of votes cast by shareholders entitled to vote at the Meeting, including a unanimous written resolution).
• · Adjournment Proposal requires an ordinary resolution (simple majority of votes cast).
• · Quorum requires a majority of shares present in person or by proxy; abstentions count toward quorum, while non-votes and abstentions have no effect on the outcome.
• · All proposals are considered non-routine, so brokers cannot vote street-name shares without client instructions.
• · Sponsors (Original and Current) have waived liquidation distribution rights on Founder Shares; Public and Private Warrants would expire worthless on liquidation.
• · Sponsors and insiders may purchase Public Shares outside the redemption offer to limit redemptions, but any such shares purchased would not be voted in favor of the Articles Extension Proposal.
• · Company does not currently anticipate seeking any further extension beyond the Articles Extension.
• · Shareholders may pre-register for the virtual meeting starting October 20, 2026, and must contact Continental for control numbers; proxy voting is available online until the Meeting.
• · Redemption payments will only be made if the Articles Extension Proposal is approved and the Company determines to implement it.

15-10-2026

Income Opportunity Realty Investors, Inc. (NYSE American: IOR) filed its definitive proxy statement (DEF 14A) on October 15, 2026, for an annual meeting of stockholders with a period of report of November 11, 2026. The filing covers board composition, committee structure, director independence determinations made in December 2025, the designation of Ted R. Munselle as Presiding Director, stockholder nomination procedures, and householding rules for annual reports and proxy materials. The excerpt contains no financial results, transaction amounts, or performance metrics, so no period-over-period comparison can be drawn from it.

• · Ted R. Munselle was designated Presiding Director by non-management directors in December 2025, serving until the annual meeting following fiscal year 2025.
• · The Board's December 2025 independence review affirmatively determined that Directors Butler, Munselle, Jakuszewski and Lara Celis are independent.
• · Mr. Munselle is designated an audit committee financial expert under SEC rules.
• · The company's Corporate Governance Guidelines reference director independence standards that meet or exceed NYSE American listing standards.
• · The company is incorporated in Nevada, is headquartered in Dallas, Texas, and its SEC file number is 001-14784.